Risperidone

Product NDC
43353-754
11-digit product format
433530754
Labeler code
43353
Product ID
43353-754_9139290e-82d1-40ea-afbe-4fd7be934799
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
risperidone
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA076288
Marketing category
ANDA
Marketing start
2008-09-17
Marketing end
0000-00-00
Substance
RISPERIDONE
Active strength
4 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6ab2126a-0ca2-c16c-ab6d-b3a031ba7ac6Product name520250303
0efa9fd6-2fb6-4cd3-8b0f-2a2bf9c4a09eProduct name120250128
e457a910-2c3a-4bfd-90b9-0310982c50ddProduct name120241218
42b1a2d5-888a-4386-ab9f-0979e0d7b4aaProduct name120231010
66685e90-862d-4873-a0c5-2be73b803c36Product name120230921
92d220a1-2a4c-4393-9080-7335ca8223ccProduct name120230823

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
43353-754-152020-01-31C16284748780-19d75b9d0-7c33-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993
43353-754-162020-01-31C16284748780-19d75b9d0-7c33-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993
43353-754-302020-01-31C16284748780-19d75b9d0-7c33-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993
43353-754-452020-01-31C16284748780-19d75b9d0-7c33-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993
43353-754-602020-01-31C16284748780-19d75b9d0-7c33-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43353-754-15Risperidone15 in 1 BOTTLE, PLASTICTABLET, FILM COATED153
43353-754-16Risperidone6000 in 1 BOTTLE, PLASTICTABLET, FILM COATED60003
43353-754-30Risperidone30 in 1 BOTTLE, PLASTICTABLET, FILM COATED303
43353-754-45Risperidone45 in 1 BOTTLE, PLASTICTABLET, FILM COATED453
43353-754-60Risperidone90 in 1 BOTTLE, PLASTICTABLET, FILM COATED903

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
43353-754-15EA - Each43353-754bb909736-d5a4-4366-99d5-6b9d708a004712014-06-03
43353-754-16EA - Each43353-754d8972afd-2fe5-4b5d-9fb9-d31daf32605c12015-01-05
43353-754-30EA - Each43353-754ddbf71fb-b7da-4ce1-94e1-55be609d2e3312014-06-03
43353-754-45EA - Each43353-7549821790b-3207-49c7-9e58-1424d618156e12014-06-03
43353-754-60EA - Each43353-754d59303b1-175a-4fdd-a367-e2d7a86a6cb212014-06-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
RISPERIDONEACTIVE INGREDIENTL6UH7ZF8HCRISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
RISPERIDONEACTIVE MOIETYL6UH7ZF8HCRISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61URISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48RISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
DOCUSATE SODIUMINACTIVE INGREDIENTF05Q2T2JA0RISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKRISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8RISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WORISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XRISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30RISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
POLYDEXTROSEINACTIVE INGREDIENTVH2XOU12IERISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ARISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4RISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EURISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JRISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPRISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3
TRIACETININACTIVE INGREDIENTXHX3C3X673RISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43353-754RISPERIDONE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]3Legacy NDC, 5 package rows20140509_50aec836-fbfd-49af-9448-912b8279a7f9.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
312830risperiDONE 1 MG Oral TabletPSN50aec836-fbfd-49af-9448-912b8279a7f93
312831risperiDONE 2 MG Oral TabletPSN50aec836-fbfd-49af-9448-912b8279a7f93
312832risperiDONE 3 MG Oral TabletPSN50aec836-fbfd-49af-9448-912b8279a7f93
314211risperiDONE 4 MG Oral TabletPSN50aec836-fbfd-49af-9448-912b8279a7f93
312830risperidone 1 MG Oral TabletSCD50aec836-fbfd-49af-9448-912b8279a7f93
312831risperidone 2 MG Oral TabletSCD50aec836-fbfd-49af-9448-912b8279a7f93
312832risperidone 3 MG Oral TabletSCD50aec836-fbfd-49af-9448-912b8279a7f93
314211risperidone 4 MG Oral TabletSCD50aec836-fbfd-49af-9448-912b8279a7f93

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
43353-754-154335307541515 in 1 BOTTLE, PLASTICHistorical
43353-754-16433530754166000 in 1 BOTTLE, PLASTICHistorical
43353-754-304335307543030 in 1 BOTTLE, PLASTICHistorical
43353-754-454335307544545 in 1 BOTTLE, PLASTICHistorical
43353-754-604335307546090 in 1 BOTTLE, PLASTICHistorical